ReviewCost effectiveness and resource allocation : C/E2023
Successes and challenges of China's health care reform: a four-decade perspective spanning 1985-2023.
Review in Cost effectiveness and resource allocation : C/E, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The prevalence of coronary microvascular dysfunction (CMD) in heart failure with preserved ejection fraction (HFpEF): a systematic review and meta-analysis.Heart failure reviews · 2024Pooled it
- Residents' preference trade-offs for critical illness insurance scheme design: a discrete choice experiment in Shandong Province, China.Health policy and planning · 2026Article
- Urban-rural disparities in injury mortality in China, 2002-2021.BMC public health · 2026Article
- Evaluation of the efficiency of county-level medical and health services under the background of county medical community policy: a case study of Sanming, China.Health economics review · 2026Article
- Bridging evidence and care for knee osteoarthritis in China: a randomized feasibility trial with RE-AIM-guided process evaluation of the PEAK-CHN model of care.Implementation science communications · 2026Article
- Impact of centralized volume-based procurement of high-value medical consumables on patients' hospitalization expenses in Gansu, China: an interrupted time series analysis.BMC health services research · 2026Article
- Spatiotemporal characteristics of health expenditure in mainland China during 2012-2020.BMC health services research · 2026Article
- Social network analysis of stakeholders in China's hierarchical medical system: toward a collaborative governance framework for enhanced integration.Frontiers in public health · 2026Article
- Education as an upstream social security intervention: constructing a competency-based talent development framework in health economics.Frontiers in public health · 2026Article
- Editorial: Innovative value-based medicine: lessons from China's healthcare evolution.Frontiers in public health · 2026Article
- From coverage to care: how basic medical insurance shapes patients' experiences of primary care in China.Frontiers in epidemiology · 2026Article
- The impact of China's drug regulatory reform on access to orphan drugs: a cross-sectional study of diseases listed in the rare disease catalog.Frontiers in pharmacology · 2026Article
- Teaching reform and practical exploration of the fundamental nursing skills course in higher vocational nursing education: a quasi-experimental study.Frontiers in medicine · 2026Article
- Financial Heterogeneity During Early Diagnosis-Related Group Payment Reform: A Two-Year Hospital-Based Study.Risk management and healthcare policy · 2026Article
- Distribution dynamics and spatial dependence in healthcare resource allocation efficiency: evidence of path dependence and club formation in China.Frontiers in public health · 2026Article
- Causes of medical disputes in China and Japan from physicians' perspectives: a qualitative study.Frontiers in health services · 2026Article
- Head Nurse Digital Leadership and Staff Nurse-GenAI Collaboration in Chinese Hospitals: The Mediating Role of Digital Self-Efficacy and the Moderating Role of Nurse Perceived Job Autonomy.Journal of nursing management · 2026Article
- Changes in Hospitalization Expenditures and Length of Stay for Patients Underwent Hysterectomy and Adnexectomy for Carcinoma in situ and Nonmalignant Lesions Diagnosis-Related Group: Impact of Beijing's Medicine-Consumables Linkage Reforms.Risk management and healthcare policy · 2026Article
- Emotional Support, Emotional Exhaustion, Mental Health, and Turnover Intention Among China Nurses in Emergency Departments: A Cross-Sectional Survey.The journal of nursing research : JNR · 2025Article
- Transformations in doctor-patient responsibilities in China's quasi-marketised healthcare system.International journal for equity in health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chinese health system remains the crucial one for understanding the wider healthcare landscape across the Global South and in particular the leading Emerging Markets. Purpose of our observation was to understand the inner dynamics of mainland Chinese health reforms adopting a lengthy time horizon. We have analysed the public reports and seminal evidence on Chinese of multiple waves of national health reforms taking place since 1980s in terms of medical care and pharmaceuticals provision and financing. Chinese international trade with ASEAN nations and wider South-East Asia is accelerating its growth after the recovery of trade routes. In terms of health sector this means that global demand and supply of medical goods, services and pharmaceuticals remains largely driven by Chinese domestic developments. Furthermore, Chinese domestic manufacturing and sales of decent quality medical devices and services have grown exponentially. Some temporary pitfalls and increasing in rural-urban inequalities in equity of access and affordability of medical care and pharmaceuticals did take place. Despite these difficulties to generate a balanced development strategy for the largest global market, this is a clear path upwards. Further upcoming improvements expanding health insurance coverage are in strong demand for certain layers of the society. Domestic bottleneck weaknesses yet remain manufacturing, import and market penetration of cutting-edge pharmaceuticals such as monoclonal antibodies and targeted oncology agents. Yet some of these obstacles are likely to be overcome in foreseeable future with the adoption of responsible strategies by governmental agencies in health care arena.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.